ZOLA, Paolo
ZOLA, Paolo
SCIENZE CHIRURGICHE
Carcinoma endometriale:terapia malattia avanzata
2004-01-01 P. Zola; E. Jacomuzzi; A. Peroglio Carus; F. Marocco
Clinicopathologic prognostic factors in endometrial cancer: a multivariate analysis in 357 patients
2007-01-01 Galletto L; Martra F; Bianciotto A; Ciancio A; Perotto S; Piovano E; Fuso L; Ferrero A; Zola P
Comorbility in endometrial cancer treated patients: risk factors or prognostic factors?
2007-01-01 Martra F; Galletto L; Ferrero A; Fuso L; Mazzola S; Piovano E; Baima Poma C; Perotto S; Zola P
Complications of the treatment of endometrial cancer: a prospective analysis using the french - italian glossary
2011-01-01 Piovano E; BaimaPoma C; Ferrero A; Fuso L; Martra F; Modaffari P; Perotto S; Tripodi E; Zanfagnin V; Zola P
Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
2007-01-01 Zola P; Fuso L; Mazzola S; Martra F; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G.
Could risk factors for spillage in laparoscopy for ovarian cysts be identified?
2011-01-01 F. Martra; P. Modaffari; E. Tripodi; V. Zanfagnin; E. Piovano; E. Volpi; L. Fuso; P. Zola
Does the best strategy for ovarian cancer exist?
2013-01-01 3. Zola P; Piovano E; Attamante L; Cavallero C; De Ruvo D; Macchi C; Mitidieri M; Vaudano A
Effectiveness of co2 laser vaporization in the treatment of vaginal intraepithelial neoplasia
2013-01-01 1. E. Piovano; C. Macchi; M. Mitidieri; L. Attamante; C. Cavallero; L. Fuso; G. Maina; L. Pasero; D. Deruvo; P. Zola
Feasibility of laparoscopy for women with ovarian cysts: how many spillages?
2009-01-01 Martra F; Modaffari P; Piovano E; Zola P; Defabiani E; Volpi E
Frequenza e fattori predittivi di reazioni acute da ipersensibilità in pazienti chemiotrattate per neoplasie ginecologiche pelviche (studio preliminare)
2008-01-01 Piovano E; Pivetta E; Ferrero A; Martra F; Modaffari P; Perotto S; Baima Poma C e Zola P
GnRH agonists and antiestrogens in the management of breast cancer.
1994-01-01 P. Sismondi; N. Biglia; D. Katsaros; M. Giai; P. Zola.
Il follow-up del carcinoma dell'ovaio:implicazione di nuovi dati d'efficenza
2009-01-01 Paolo Zola; Angiolo Gadducci; Fabio Landoni; Tiziano Maggino; Enrico Sartori; Luca Fuso; Elisa Piovano; Stefania Perotto; Cinzia Baima Poma; Elisa Tripodi; Valentina Zanfagnin
Infertility as a negative prognostic factor in endometrial cancer: analysis in 357 patients treated at the university hospital of Turin
2007-01-01 Martra F; Galletto L; Bianciotto A; Garetto A; Baima Poma C; Piovano E; Fuso L; Ferrero A; Zola P
Integrated treatment in cervical cancer: costs and benefits
2013-01-01 Zola P; Piovano E; Attamante L; Cavallero C; De Ruvo D; Macchi C; Mitidieri M
Is there a difference in survival and in prognostic factors in stage IIA and stage IIB endometrial cancer patients?
2006-01-01 Martra F; Kunos C; Galletto L; Fuso L; Piovano E; Ferrero A; Von Gruenigen VE; Zola P
IS ULTRASOUND A GOOD EXAM TO EVALUATE PATIENTS WITH OVARIAN MASSES BEFORE SURGERY?
2010-01-01 F. Martra; P. Modaffari; E. Piovano; C. Baima Poma; E. Tripodi; V. Zanfagnin; E. Volpi; P. Zola
Missing data imputation in longitudinal trial of endometrial cancer patients
2016-01-01 Rosato, R; Pagano, E; Piovano, E; Fuso, L; Tripodi, E; Mitidieri, M; Ceccarelli, M; Zola, P; Di Cuonzo, D
Monitoraggio del Paclitaxel in pazienti affetti da carcinoma ovarico o mammario
1997-01-01 D. Nanni; P. Crosasso; P. Brusa; L. Cattel; P. Zola; M. Marengo; M. Miglietta
PATTERN OF FAILURES AND PROGNOSTIC FACTORS IN TYPE 2 ENDOMETRIAL CARCINOMA: A SINGLE INSTITUTION RETROSPECTIVE STUDY
2010-01-01 V. Zanfagnin; E. Tripodi; F. Marocco; E. Piovano; L. Fuso; A. Ferrero; N. Ravarino; P. Zola
Phase I/II study with pegylated liposomal doxorubicin and prolonged infusion gemcitabine in recurrent ovarian cancer
2009-01-01 Ferrero A; Baima Poma C; Cattel L; Piovano E; Perotto S; Modaffari P; Dompè D; Zola P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Carcinoma endometriale:terapia malattia avanzata | 2004 | P. Zola; E. Jacomuzzi; A. Peroglio Carus; F. Marocco | |
| Clinicopathologic prognostic factors in endometrial cancer: a multivariate analysis in 357 patients | 2007 | Galletto L; Martra F; Bianciotto A; Ciancio A; Perotto S; Piovano E; Fuso L; Ferrero A; Zola P | |
| Comorbility in endometrial cancer treated patients: risk factors or prognostic factors? | 2007 | Martra F; Galletto L; Ferrero A; Fuso L; Mazzola S; Piovano E; Baima Poma C; Perotto S; Zola P | |
| Complications of the treatment of endometrial cancer: a prospective analysis using the french - italian glossary | 2011 | Piovano E; BaimaPoma C; Ferrero A; Fuso L; Martra F; Modaffari P; Perotto S; Tripodi E; Zanfagnin V; Zola P | |
| Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. | 2007 | Zola P; Fuso L; Mazzola S; Martra F; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G. | |
| Could risk factors for spillage in laparoscopy for ovarian cysts be identified? | 2011 | F. Martra; P. Modaffari; E. Tripodi; V. Zanfagnin; E. Piovano; E. Volpi; L. Fuso; P. Zola | |
| Does the best strategy for ovarian cancer exist? | 2013 | 3. Zola P; Piovano E; Attamante L; Cavallero C; De Ruvo D; Macchi C; Mitidieri M; Vaudano A | |
| Effectiveness of co2 laser vaporization in the treatment of vaginal intraepithelial neoplasia | 2013 | 1. E. Piovano; C. Macchi; M. Mitidieri; L. Attamante; C. Cavallero; L. Fuso; G. Maina; L. Pasero; D. Deruvo; P. Zola | |
| Feasibility of laparoscopy for women with ovarian cysts: how many spillages? | 2009 | Martra F; Modaffari P; Piovano E; Zola P; Defabiani E; Volpi E | |
| Frequenza e fattori predittivi di reazioni acute da ipersensibilità in pazienti chemiotrattate per neoplasie ginecologiche pelviche (studio preliminare) | 2008 | Piovano E; Pivetta E; Ferrero A; Martra F; Modaffari P; Perotto S; Baima Poma C e Zola P | |
| GnRH agonists and antiestrogens in the management of breast cancer. | 1994 | P. Sismondi; N. Biglia; D. Katsaros; M. Giai; P. Zola. | |
| Il follow-up del carcinoma dell'ovaio:implicazione di nuovi dati d'efficenza | 2009 | Paolo Zola; Angiolo Gadducci; Fabio Landoni; Tiziano Maggino; Enrico Sartori; Luca Fuso; Elisa Piovano; Stefania Perotto; Cinzia Baima Poma; Elisa Tripodi; Valentina Zanfagnin | |
| Infertility as a negative prognostic factor in endometrial cancer: analysis in 357 patients treated at the university hospital of Turin | 2007 | Martra F; Galletto L; Bianciotto A; Garetto A; Baima Poma C; Piovano E; Fuso L; Ferrero A; Zola P | |
| Integrated treatment in cervical cancer: costs and benefits | 2013 | Zola P; Piovano E; Attamante L; Cavallero C; De Ruvo D; Macchi C; Mitidieri M | |
| Is there a difference in survival and in prognostic factors in stage IIA and stage IIB endometrial cancer patients? | 2006 | Martra F; Kunos C; Galletto L; Fuso L; Piovano E; Ferrero A; Von Gruenigen VE; Zola P | |
| IS ULTRASOUND A GOOD EXAM TO EVALUATE PATIENTS WITH OVARIAN MASSES BEFORE SURGERY? | 2010 | F. Martra; P. Modaffari; E. Piovano; C. Baima Poma; E. Tripodi; V. Zanfagnin; E. Volpi; P. Zola | |
| Missing data imputation in longitudinal trial of endometrial cancer patients | 2016 | Rosato, R; Pagano, E; Piovano, E; Fuso, L; Tripodi, E; Mitidieri, M; Ceccarelli, M; Zola, P; Di Cuonzo, D | |
| Monitoraggio del Paclitaxel in pazienti affetti da carcinoma ovarico o mammario | 1997 | D. Nanni; P. Crosasso; P. Brusa; L. Cattel; P. Zola; M. Marengo; M. Miglietta | |
| PATTERN OF FAILURES AND PROGNOSTIC FACTORS IN TYPE 2 ENDOMETRIAL CARCINOMA: A SINGLE INSTITUTION RETROSPECTIVE STUDY | 2010 | V. Zanfagnin; E. Tripodi; F. Marocco; E. Piovano; L. Fuso; A. Ferrero; N. Ravarino; P. Zola | |
| Phase I/II study with pegylated liposomal doxorubicin and prolonged infusion gemcitabine in recurrent ovarian cancer | 2009 | Ferrero A; Baima Poma C; Cattel L; Piovano E; Perotto S; Modaffari P; Dompè D; Zola P |